Tango Therapeutics, Inc. · NASDAQ:TNGX

Crystal Adam sold 5,000 Tango Therapeutics, Inc. shares (Form 4)

Traded Nov 11, 2026 · Filed Nov 13, 2026

On Nov 11, 2026, Crystal Adam (President, R&D) sold 5,000 Tango Therapeutics, Inc. shares at US$25.00 for US$125K under a trading plan, leaving 115,743 shares. Filed Nov 13, 2026 (Form 4).

Sold
5,000 shares
Price
US$25.00
Value
US$125K
Holding after
115,743 shares
Trading plan
Yes (Made under a plan set in advance)
Role
President, R&D

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 11, 2026Common StockOption exercise5,000US$2.91120,743Direct
Nov 11, 2026Common StockSale5,000US$25.00115,743Direct

Source

Download original · View original at SEC

Related